This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kazuma Suda: Innovator in Mesenchymal Stem Cell Research
Introduction
Kazuma Suda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of regenerative medicine, particularly through his work on mesenchymal stem cells. His innovative research aims to enhance therapeutic effects against various diseases.
Latest Patents
Kazuma Suda holds a patent for "ROR1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ROR1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating disease using ROR1-positive mesenchymal stem cells." This invention focuses on providing novel mesenchymal stem cells that demonstrate superior therapeutic effects. The ROR1-positive mesenchymal stem cells are characterized by their positivity for CD29, CD73, CD90, CD105, and CD166, and are derived from umbilical cord or adipose tissue. He has 1 patent in this area.
Career Highlights
Kazuma Suda is associated with Rohto Pharmaceutical Co., Ltd., where he continues to advance his research in stem cell technology. His work is pivotal in developing new treatments that leverage the unique properties of ROR1-positive mesenchymal stem cells.
Collaborations
He collaborates with notable colleagues such as Yoshifumi Ikeyama and Hiroyuki Nishida, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kazuma Suda's contributions to the field of mesenchymal stem cells represent a significant advancement in regenerative medicine. His innovative work continues to pave the way for new therapeutic approaches to treat various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile